Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10145 | 31470247 | J Trace Elem Med Biol | Aluminium levels in hair and urine are associated with overweight and obesity in a non-occupationally exposed population. | 2019 | Details |
| A10149 | 31469122 | Pol Arch Intern Med | Serum pentraxin 3 concentration in patients with type 2 diabetes and nonalcoholic fatty liver disease. | 2019 | Details |
| A10154 | 31466361 | Int J Environ Res Public Health | Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10157 | 31464788 | Eur J Gastroenterol Hepatol | The performance of M and XL probes of FibroScan for the diagnosis of steatosis and fibrosis on a Brazilian nonalcoholic fatty liver disease cohort. | 2020 | Details |
| A10175 | 31452288 | Phytother Res | Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice. | 2019 | Details |
| A10180 | 31447605 | Malays J Med Sci | The 2017 M Balasegaram Memorial Lecture: The Changing Landscape of Liver Diseases in Malaysia-60 Years On! | 2019 | Details |
| A10197 | 31438482 | Int J Environ Res Public Health | Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. | 2019 | Details |
| A10202 | 31435201 | Gastroenterol Hepatol (N Y) | Implications of Nonalcoholic Fatty Liver Disease on Pregnancy and Maternal and Child Outcomes. | 2019 | Details |
| A10210 | 31430977 | Int J Mol Sci | Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders. | 2019 | Details |
| A10238 | 31418344 | Curr Vasc Pharmacol | What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis? | 2019 | Details |
| A10249 | 31412267 | Eur J Pharmacol | Liraglutide improves insulin sensitivity in high fat diet induced diabetic mice through multiple pathways. | 2019 | Details |
| A10253 | 31410151 | Exp Ther Med | Association between abdominal obesity and liver steatosis and fibrosis among patients with chronic hepatitis B measured by Fibroscan. | 2019 | Details |
| A10268 | 31405697 | Diabetes Metab Syndr | Partitioning of radiological, stress and biochemical changes in pre-diabetic women subjected to Diabetic Yoga Protocol. | 2019 | Details |
| A10307 | 31391764 | World J Gastroenterol | Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease. | 2019 | Details |
| A10309 | 31390852 | Turk J Med Sci | Association between PPARGC1A single nucleotide polymorphisms and increased risk of nonalcoholic fatty liver disease among Iranian patients with type 2 diabetes mellitus | 2019 | Details |
| A10316 | 31388695 | Diabetologia | Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis. | 2019 | Details |
| A10324 | 31387736 | Lancet Gastroenterol Hepatol | Management of metabolic syndrome and cardiovascular risk after liver transplantation. | 2019 | Details |
| A10339 | 31384519 | Biosci Microbiota Food Health | The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms. | 2019 | Details |
| A10349 | 31379820 | Front Immunol | Tissue Immune Cells Fuel Obesity-Associated Inflammation in Adipose Tissue and Beyond. | 2019 | Details |
| A10356 | 31377187 | Nutr Metab Cardiovasc Dis | PNPLA3 gene polymorphism in Brazilian patients with type 2 diabetes: A prognostic marker beyond liver disease? | 2019 | Details |
| A10360 | 31375010 | Int J Environ Res Public Health | Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10377 | 31366455 | Gut | Epidemiology of chronic liver diseases in the USA in the past three decades. | 2019 | Details |
| A10401 | 31353974 | Expert Rev Gastroenterol Hepatol | Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations. | 2019 | Details |
| A10406 | 31351021 | Diabetes Metab Res Rev | C-peptide is associated with NAFLD inflammatory and fibrotic progression in type 2 diabetes. | 2019 | Details |
| A10414 | 31345776 | Lancet Diabetes Endocrinol | Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. | 2019 | Details |
| A10431 | 31338545 | Diabetologia | A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial. | 2019 | Details |
| A10437 | 31336526 | Diabetes Metab Syndr | Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran. | 2019 | Details |
| A10438 | 31336502 | Diabetes Metab Syndr | The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes. | 2019 | Details |
| A10442 | 31336149 | Biochim Biophys Acta Mol Basis Dis | The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver. | 2019 | Details |
| A10452 | 31332029 | Diabetes Care | Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial. | 2019 | Details |
| A10457 | 31328300 | Aliment Pharmacol Ther | Depression is associated with non-alcoholic fatty liver disease among adults in the United States. | 2019 | Details |
| A10459 | 31328066 | Cureus | A Retrospective Study to Examine the Correlation of Bioelectrical Impedance Analysis with Shear-wave Elastography in Indian Patients with Non-alcoholic Fatty Liver Disease and Diabetes on Background Sodium-glucose Cotransporter-2 Inhibitor Therapy. | 2019 | Details |
| A10461 | 31326267 | J Diabetes Complications | Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis. | 2019 | Details |
| A10470 | 31324087 | J Assoc Physicians India | Effects of Canagliflozin on Abnormal Liver Function Tests in Patients of Type 2 Diabetes with Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A10476 | 31321014 | Ther Adv Chronic Dis | Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus. | 2019 | Details |
| A10486 | 31315613 | BMC Endocr Disord | The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes. | 2019 | Details |
| A10493 | 31312893 | Abdom Radiol (NY) | Relationship between abdominal fat stores and liver fat, pancreatic fat, and metabolic comorbidities in a pediatric population with non-alcoholic fatty liver disease. | 2019 | Details |
| A10502 | 31309820 | Curr Vasc Pharmacol | Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review. | 2019 | Details |
| A10512 | 31308341 | Intern Med | The Long-term Efficacy of Sodium Glucose Co-transporter 2 Inhibitor in Patients with Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A10520 | 31304703 | J Assoc Physicians India | Association of Genetic Non-alcoholic Fatty Liver Disease with Insulin Resistance-Are we Different? | 2019 | Details |
| A10525 | 31301321 | J Hepatol | Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease. | 2019 | Details |
| A10535 | 31298151 | Curr Pharm Des | Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus. | 2019 | Details |
| A10547 | 31293337 | World J Gastroenterol | Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. | 2019 | Details |
| A10550 | 31292843 | Clin J Gastroenterol | Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus. | 2019 | Details |
| A10551 | 31292564 | Nat Rev Rheumatol | Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions. | 2019 | Details |
| A10558 | 31291052 | Diabetes Metab Res Rev | Metabolically healthy obesity increased diabetes incidence in a middle-aged and elderly Chinese population. | 2019 | Details |
| A10571 | 31284538 | Molecules | The Modulatory Action of Vitamin D on the Renin-Angiotensin System and the Determination of Hepatic Insulin Resistance. | 2019 | Details |
| A10587 | 31279904 | J Hepatol | Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease. | 2019 | Details |
| A10588 | 31279902 | J Hepatol | The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. | 2019 | Details |
| A10591 | 31278754 | J Physiol | Liver sympathetic denervation reverses obesity-induced hepatic steatosis. | 2019 | Details |
| A10608 | 31273595 | Dig Dis Sci | Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, China. | 2019 | Details |
| A10640 | 31258138 | Turk J Gastroenterol | Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience. | 2019 | Details |
| A10641 | 31258135 | Turk J Gastroenterol | Non-alcoholic fatty liver disease: A growing public health problem in Turkey. | 2019 | Details |
| A10658 | 31251092 | Curr Med Res Opin | Phenotypic characteristics and risk factors in a multi-ethnic cohort of young adults with type 2 diabetes. | 2019 | Details |
| A10662 | 31246368 | Aliment Pharmacol Ther | Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity. | 2019 | Details |
| A10663 | 31246081 | Eur J Paediatr Dent | The sweet danger of added sugars. | 2019 | Details |
| A10684 | 31236937 | Australas J Dermatol | Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk. | 2019 | Details |
| A10685 | 31236880 | Bull Exp Biol Med | Effect of Linagliptin on the Ratio of Apoptosis Regulators in the Model of Non-Alcoholic Fatty Liver Disease in db/db Mice. | 2019 | Details |
| A10690 | 31235161 | Diabetes Metab Syndr | Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients. | 2019 | Details |
| A10691 | 31235092 | Diabetes Metab Syndr | Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DM. | 2019 | Details |
| A10699 | 31233505 | PLoS One | Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats. | 2019 | Details |
| A10720 | 31222979 | J Cell Mol Med | Hepatic functional and pathological changes of type 1 diabetic mice in growing and maturation time. | 2019 | Details |
| A10723 | 31221701 | Diabetes Care | Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes. | 2019 | Details |
| A10729 | 31219362 | Infect Dis (Lond) | Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A10731 | 31219051 | JMIR Res Protoc | Diet-Induced Alteration of Microbiota and Development of Obesity, Nonalcoholic Fatty Liver Disease, and Diabetes: Study Protocol of a Prospective Study. | 2019 | Details |
| A10734 | 31216433 | J Ethnopharmacol | Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice. | 2019 | Details |
| A10749 | 31211621 | Am J Physiol Endocrinol Metab | Mouse trefoil factor 3 ameliorated high-fat-diet-induced hepatic steatosis via increasing peroxisome proliferator-activated receptor-α-mediated fatty acid oxidation. | 2019 | Details |
| A10751 | 31210034 | Diabetes Metab J | Understanding Bile Acid Signaling in Diabetes: From Pathophysiology to Therapeutic Targets. | 2019 | Details |
| A10752 | 31209928 | J Hum Nutr Diet | Prospective study of perceived dietary salt intake and the risk of non-alcoholic fatty liver disease. | 2019 | Details |
| A10755 | 31208414 | Cardiovasc Diabetol | New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence. | 2019 | Details |
| A10756 | 31208147 | Nutrients | Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases. | 2019 | Details |
| A10758 | 31207986 | J Clin Med | Effect of Short Term Intensive Lifestyle Intervention on Hepatic Steatosis Indexes in Adults with Obesity and/or Type 2 Diabetes. | 2019 | Details |
| A10760 | 31206765 | Echocardiography | Evaluation of left atrial function in type 2 diabetes mellitus patients with nonalcoholic fatty liver disease by two-dimensional speckle tracking echocardiography. | 2019 | Details |
| A10777 | 31197470 | Acta Diabetol | Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients. | 2019 | Details |
| A10783 | 31195434 | Gut Liver | Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A10786 | 31193303 | J Adv Res | Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review. | 2018 | Details |
| A10806 | 31181641 | J Clin Med | Bile Acid and Fibroblast Growth Factor 19 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Sleeve Gastrectomy. | 2019 | Details |
| A10810 | 31177662 | Zhonghua Gan Zang Bing Za Zhi | [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease]. | 2019 | Details |
| A10815 | 31176297 | Eur J Endocrinol | Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study. | 2019 | Details |
| A10817 | 31175629 | Curr Obes Rep | Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives. | 2019 | Details |
| A10850 | 31157422 | Aliment Pharmacol Ther | Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis. | 2019 | Details |
| A10859 | 31153588 | Acta Histochem | A histomorphometric study on the hepatoprotective effects of a green rooibos extract in a diet-induced obese rat model. | 2019 | Details |
| A10874 | 31145699 | JCI Insight | A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans. | 2019 | Details |
| A10882 | 31142104 | Clin Mol Hepatol | Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes. | 2019 | Details |
| A10891 | 31137547 | Medicina (Kaunas) | Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10897 | 31135513 | Eur J Gastroenterol Hepatol | Fibroscan and low-density lipoprotein as determinants of severe liver fibrosis in diabetic patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A10905 | 31131845 | Clin Infect Dis | Natural Course of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Patients With Human Immunodeficiency Virus With and Without Combination Antiretroviral Therapy-associated Lipodystrophy: A 16-Year Follow-up Study. | 2020 | Details |
| A10906 | 31131357 | Ann Gastroenterol Surg | Improvement of non-alcoholic fatty liver disease after laparoscopic sleeve gastrectomy in Japanese obese patients. | 2019 | Details |
| A10932 | 31115065 | J Gastroenterol Hepatol | Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle-aged patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A10942 | 31112805 | J Glob Antimicrob Resist | Refractory Helicobacter pylori gastritis: The hidden predictors of resistance. | 2019 | Details |
| A10946 | 31109939 | Diabetes | The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism. | 2019 | Details |
| A10957 | 31104052 | Obes Facts | SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy. | 2019 | Details |
| A10966 | 31100460 | Clin Gastroenterol Hepatol | Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes. | 2019 | Details |
| A10969 | 31098621 | Endocr Rev | The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance. | 2019 | Details |
| A10986 | 31090267 | J Zhejiang Univ Sci B | Bile-ology: from bench to bedside. | 2019 | Details |
| A10989 | 31089576 | J Obes Metab Syndr | The Effects of Hypoglycemic Agents on Non-alcoholic Fatty Liver Disease: Focused on Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. | 2019 | Details |
| A10990 | 31089474 | J Diabetes Res | Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link? | 2019 | Details |
| A10993 | 31088856 | Diabetes | Liver Function and Risk of Type 2 Diabetes: Bidirectional Mendelian Randomization Study. | 2019 | Details |
| A10999 | 31085617 | Postgrad Med J | Diagnosis and management of non-alcoholic fatty liver disease. | 2019 | Details |
| A11014 | 31081822 | J Vis Exp | An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes. | 2019 | Details |